Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of August 5, 2025 • 7:01 PM ET

Date/Time Source News Release
07/23/2025 07:05 AM EDT GlobeNewswire Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada
07/17/2025 07:05 AM EDT GlobeNewswire Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline
06/17/2025 07:05 AM EDT GlobeNewswire Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting
05/21/2025 07:05 AM EDT GlobeNewswire Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum
05/14/2025 04:05 PM EDT GlobeNewswire Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update
05/09/2025 07:05 AM EDT GlobeNewswire Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
05/08/2025 07:05 AM EDT GlobeNewswire Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
05/01/2025 07:05 AM EDT GlobeNewswire Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference
04/01/2025 07:05 AM EDT GlobeNewswire Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
03/27/2025 04:05 PM EDT GlobeNewswire Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Page

Additional News

As of August 5, 2025 • 7:01 PM ET

Date/Time Source News Release
07/23/2025 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Wed, Jul 23, 2025 as of 4:00 pm ET
07/23/2025 12:06 PM EDT 24/7 Market News Biotech in Focus: Regulatory Wins, Strategic Moves, and Speculative Momentum
07/23/2025 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Wed, Jul 23, 2025 as of 10.00 am ET
07/23/2025 08:53 AM EDT 24/7 Market News Clearside Biomedical Secures Canadian Approval for XIPERE as Suprachoroidal Treatment for Uveitic Macular Edema
07/18/2025 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Fri, Jul 18, 2025 as of 4:00 pm ET
06/12/2025 11:03 AM EDT SeekingAlpha EyePoint Stock: Retaining My 'Risky Buy' Call - Pivotal Data Due Early 2026
05/29/2025 12:00 PM EDT Zacks Clearside Biomedical (CLSD) Upgraded to Buy: Here's What You Should Know
05/14/2025 05:35 PM EDT Zacks Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Tops Revenue Estimates
05/14/2025 04:13 PM EDT SeekingAlpha Clearside Biomedical GAAP EPS of -$0.11 in-line, revenue of $2.3M beats by $2.1M
05/14/2025 10:00 AM EDT SeekingAlpha Here are the major earnings after the close today
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.